Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Dean Fergusson a Ottawa Health Research Institute, 501 Smyth
Road, Box 201, Ottawa, ON, Canada K1H 8L6, b Departments of Clinical Epidemiology and Biostatistics and
Medicine, McMaster University, Hamilton, ON, Canada L8N
3Z5 Correspondence
to: D Fergusson dafergusson@ohri.ca
| The first 150 words of the full text of this article appear below. |
When is it legitimate to exclude randomised patients from the analysis of data in clinical trials? Basing their analysis on the desirability of minimising bias and random error, the authors consider the circumstances when it may be possible to exclude patients, even in an intention to treat trial
Most clinical researchers and statisticians agree that the primary analysis of data in a randomised clinical trial should compare patients according to the group to which they were randomly allocated, regardless of patients' compliance, crossover to other treatments, or withdrawal from the study. Such an analysis is referred to as an intention to treat or an "as randomised" analysis. Proponents argue that the intention to treat approach
Read all Rapid Responses